CME Webcast Discusses Use and Complications of NSAIDs

OSUWexnerbloglogo2014 CME Webcast Discusses Use and Complications of NSAIDs. We have lots of choices of NSAIDs and these drugs can be highly effective in relieving pain and suffering. But they can also have serious side effects. On this CME webcast, we’re going to explore the use and the complications of non-steroidal anti-inflammatory drugs. Joining our moderator in the studio is rheumatologist and Assistant Professor of Internal Medicine, Dr. Sheryl Mascarenhas.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: GAIN an enhanced understanding of NSAID use with regard to various clinical scenarios and patient comorbidities; and IMPROVE familiarity with complications of NSAIDs and better understand ways to limit these complications.

You’ll also learn about the following:

  • Whether all NSAIDs equally effective
  • Whether all NSAIDs have the same side effects
  • Intravenous NSAIDs
  • Rofecoxib (Vioxx)

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Get an Understanding of Healthcare Disparities Viewing CME Webcast

OSUWexnerbloglogo2014 Get an understanding of healthcare disparities viewing CME webcast. On this CME webcast, we’re going to take a look at why disparities exist in healthcare in the United States and what we can do to ensure that all Americans, regardless of race, gender, or ethnicity, have an equal access to healthcare and an equal outcome from healthcare. Joining our moderator in the studio is gastroenterologist and Assistant Professor of Internal Medicine from the Ohio State University, Dr. Darrell Gray, II. Dr. Gray is also the Deputy Director for the Center for Cancer Health Equity at the OSU Comprehensive Cancer Center.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DESCRIBE the historical context, landmark reports, and etiologies of healthcare disparities; and IDENTIFY practical strategies in reducing health disparities.

You’ll also learn about the following:

  • Healthcare disparities in America
  • Opportunities to improve for all physicians
  • Changes in physician and medical student racial demographics
  • How the Affordable Care Act impacts healthcare disparities
  • Personalized medicine and elimination of disparities
  • Disparities in clinical trials

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

New Developments in Lung Cancer Treatment

OSUWexnerbloglogo2014 New Developments in Lung Cancer Treatment. Lung cancer now accounts for 14% of all cancers but it is the most common cause of cancer death, In fact, more people die each year from lung cancer than from colon cancer, breast cancer, and prostate cancer combined. The 5-year survival rate of lung cancer is only 18% but the good news is that we have a lot of new medications that are giving patients with lung cancer longer and better lives. On our CME webcast, to discuss new treatments in lung cancer, are two of Ohio State’s experts in the management of lung cancer. Joining our moderator, Dr. Jim Allen, we have Dr. Greg Otterson who is a Professor of Internal Medicine from the Division of Medical Oncology and Dr. Erin Bertino, an Assistant Professor of Internal Medicine, also from the Division of Medical Oncology.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: GAIN an understanding of the importance of genomic testing in the initial workup of patients with lung cancer. EXPLAIN the evolving role of immune mediated therapy in lung cancer; RECOGNIZE the clinical benefit for patients receiving targeted therapies; and DESCRIBE the patient characteristics commonly associated with actionable mutations in lung cancer.

You’ll also learn about the following:

  • The most fatal of all common cancers
  • Evolving chemotherapy treatment of lung cancer
  • Sub-classifying adenocarcinomas
  • Squamous cell lung cancer treatment
  • Large cell undifferentiated lung cancer

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Education for Managing Asthma for Children and Adults

OSUWexnerbloglogo2014 On-line Education for Managing Asthma for Children and Adults. The first asthma inhalers were marketed in 1956 and contained epinephrine and isoprenaline. We now have much better medications to put into inhalers but it is still a big business, for example, just one of the 3 brands of albuterol inhalers had more than one billion dollars in sales last year. On this CME webcast, we’re going to update you on asthma. First, to tell you about asthma in adults is Associate Professor of Internal Medicine and the Fellowship Director for adult pulmonary at Ohio State, Dr. Jennifer McCallister. Then, to tell you about asthma in children is Associate Professor of Pediatrics and the Fellowship Director for pediatric pulmonary at Ohio State and Nationwide Children’s Hospital, Dr. Elizabeth Allen.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: SELECT age appropriate “step-up” therapies for children with uncontrolled asthma; INSTRUCT all asthma patients on appropriate steps to take during an asthma flare; USE the domains of impairment and risk to characterize asthma severity and control; and DESCRIBE commonly available tools to objectively characterize asthma control

You’ll also learn about the following:

  • Asthma signs and symptoms
  • Pathophysiology of asthma
  • Allergy testing and asthma
  • Adult-onset asthma
  • Inhaled medication delivery in younger children
  • When you should refer asthmatic children to the pediatric asthma specialist
  • Management of acute exacerbations of asthma
  • Asthma during pregnancy
  • Common asthma mimics in children
  • The role of the school nurse in the management of childhood asthma
  • Choosing among different steroid and steroid/LABA inhalers
  • Allergic bronchopulmonary aspergillosis
  • Asthma medication de-escalation

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

View Webcast Education on Healthcare Literacy

OSUWexnerbloglogo2014View Webcast Education on Healthcare Literacy by watching our latest installment of our on-line education series, MedNet21. Ask yourself, are you a great communicator? It doesn’t matter what the name of the university is on your medical diploma or the name of the hospital on your residency certificate or how good of a doctor you really are, if you can’t communicate with your patients, then none of that really matters.  For this webcast, we’re going to take a close look at communication and give you the tools you need in order to be sure that you can communicate effectively with all of the patients in your practice. On this webcast, joining our moderator Dr. Jim Allen, we have Associate Professor in the Department of Family Medicine, Dr. Lorraine Wallace.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DEPICT health literacy skills of American adults and DESCRIBE the strong link between health literacy skills and health-related outcomes.

You’ll also learn about the following:

  • Whether physicians are effective communicators
  • Computer use and health literacy
  • Health literacy and the affordable care act
  • Communication effectiveness of different healthcare providers
  • Health literacy outside of the United States

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.